iMols, the collaborative platform for computational drug discovery, was closed last July 1st, 2016. All iMols users can now enjoy Mind the Byte's SaaS platform with more and exciting features. What do we offer?
- 2D virtual profiling in less than 5 minutes (Cabrakan)
- 2D virtual screening (Chaac)
- 2D ligand-based compound selection (Kizin)
- 3D ligand-based virtual profiling (Hurakan)
- 3D virtual screening (Ik)
- 3D protein-based virtual profiling (Ixchel)
- 3D protein-based virtual screening (Itzamna)
- Management of chemical libraries (Ixtab)
- Blind-docking technology (Kin)
If you have any doubts, don't hesitate to contact us.